Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Tuberous sclerosis presenting with confusion and agitation

Shruthi Konda
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.11-5-502
Clin Med October 2011
Shruthi Konda
Ealing Hospital, Middlesex
Roles: Core medical trainee, respiratory medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shruthi.konda@doctors.org.uk
  • Article
  • Info & Metrics
Loading

This lesson describes a case of tuberous sclerosis presenting with confusion and agitation. The condition is briefly reviewed and learning points are emphasised for clinicians encountering similar presentations.

Lesson

A 59-year-old lady with a background of moderate-to-severe learning difficulties and epilepsy was admitted with confusion and agitation. Her medication consisted of diazepam 10 mg TDS and phenytoin 100 mg TDS. On inspection she had an erythematous nasolabial rash. Examination of her cardiovascular, respiratory and abdominal systems was unremarkable. Of note in her neurological examination were absent knee-jerk reflexes.

Her blood tests were fairly unremarkable with the only abnormalities being a mildly elevated alkaline phosphatase (ALP) of 122 (32–120 u/l) and an elevated phenytoin level at 25 (10–20 mg/l). Her chest and abdominal radiographs were normal. A previous computed tomography (CT) head scan from a year ago was reviewed and revealed small vessel disease suggesting vascular dementia.

A review from the psychiatrists suggested that her acute-on-chronic confusional state was probably due to vascular dementia; with phenytoin toxicity being suggested as a differential diagnosis. Her phenytoin dosing was optimised, and her confusional state was managed with diazepam and quetiapine. The patient improved gradually and was discharged home.

Unfortunately, the patient was readmitted the next day with right-sided facial twitching and periorbital bruising. Her bloods revealed no new abnormalities. A urine dipstick and culture were positive for a urinary tract infection for which antibiotic treatment was commenced. A head CT and orbits were also obtained which revealed multiple calcific densities in the periventricular/subependymal region as well as in the caudothalamic groove; which are in keeping with tuberous sclerosis–a diagnosis that had not previously been made. A subsequent dermatological review of the patient with the diagnosis in mind revealed other features of tuberous sclerosis (TS), namely adenoma sebaceum and subungual fibromas.

The patient and her family were informed of the diagnosis and the patient is currently obtaining genetic counselling.

Discussion

TS is a rare, inherited neurocutaneous disorder. It is autosomal dominant with an incidence of approximately one in 5,000–10,000 live births.1 However, only one third of the cases are familial.2

Two distinct genetic loci responsible for TS have been identified: one on chromosome band 9q34 (referred to as TSC1) and another on chromosome band 16p13 (TSC2).3 The TSC1 gene encodes hamartin and the TSC2 gene encodes the tuberin protein. Normally, the hamartin forms a complex with the tuberin protein, which then acts as a negative regulator of the cell cycle. In the absence of the functional tuberin–hamartin complex, cells spend less time in G1 (resting-phase of the cell cycle) and quiescent cells are induced to enter the cell cycle4,5 possibly leading to the formation of multiple benign neoplasms of the brain, kidney and skin–the clinical features of TS.

The diagnostic criteria for TS are based upon specific clinical features (Boxes 1 and 2).

Box 1.

The major features of tuberous sclerosis.


Embedded Image
Box 2.

The minor features of tuberous sclerosis.


Embedded Image

The diagnosis of TS requires two major features, or one major feature and two minor features. The more recognised triad of seizures, mental retardation and facial angiofibromas (Vogt's triad) occurs in fewer than 50% of patients with TS.7

TS is a rare disease and therefore not in the forefront of the clinician's mind. Also, the awareness of the disease is usually limited to Vogt's triad or to individuals with severe neurological pathology. TS can present at any age with a varying phenotype. Therefore establishing the clinical diagnosis of TS is exceedingly difficult. Consequently, the true prevalence of the disease within the population might be greater than that which is known.

A recent study estimated total population prevalence between about seven and 12 cases per 100,000, with more than half of these being undetected.8 The total population prevalence figures have steadily increased from 1:150,000 in 1956, to 1:100,000 in 1968, to 1:70,000 in 1971, to 1:34,200 in 1984, to the present figure of 1:12,500 in 1998. One possible explanation for this could be the use of imaging techniques, such as ultrasound, CT and MRI, which have enabled the diagnosis of difficult and also many non-symptomatic cases of TS.

It was imaging that eventually led to this patient's diagnosis and its importance in diagnosing patients with rare genetic disorders needs to be recognised.

  • © 2011 Royal College of Physicians

References

  1. ↵
    1. Osborne JP,
    2. Fryer A,
    3. Webb D
    . Epidemiology of tuberous sclerosis. Ann N Y Sci 1991: 615–125doi:10.1111/j.1749-6632.1991.tb37754.x
    OpenUrlCrossRef
  2. ↵
    1. Rose VM,
    2. Au KS,
    3. Pollom G,
    4. et al
    . Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 1999; 64: 986doi:10.1086/302322
    OpenUrlCrossRefPubMed
  3. ↵
    1. Sampson JR,
    2. Harris PC
    . The molecular genetics of tuberous sclerosis. Human Mol Genet 1994; 3: 14–77doi:10.1093/ndt/11.supp6.34
    OpenUrlCrossRef
  4. ↵
    1. Soucek T,
    2. Yeung RS,
    3. Hengstschlager M
    . Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.. Proc Natl Acad Sci USA 1998; 95: 156–53doi:10.1073/pnas.95.26.15653
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Soucek T,
    2. Pusch O,
    3. Wienceke R,
    4. et al
    . Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.. J Biol Chem 1997; 272: 293–301doi:10.1074/jbc.272.46.29301
    OpenUrlCrossRef
    1. Roach E,
    2. Sparagana S
    . Diagnosis of tuberous sclerosis complex.. J Child Neurol 2004; 19: 643–301doi:10.1002/9783527630073.ch3
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Roach ES,
    2. Gomez MR,
    3. Northrup H
    . Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998: 13–624doi:10.1177/088307389801301206
    OpenUrlCrossRef
  7. ↵
    1. O'Callaghan FJK,
    2. Shiell AW,
    3. Osborne JP,
    4. Martyn CN
    . Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 1998; 351: 14–301doi:10.1016/S0140-6736(05)78872-3
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Tuberous sclerosis presenting with confusion and agitation
Shruthi Konda
Clinical Medicine Oct 2011, 11 (5) 502-503; DOI: 10.7861/clinmedicine.11-5-502

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tuberous sclerosis presenting with confusion and agitation
Shruthi Konda
Clinical Medicine Oct 2011, 11 (5) 502-503; DOI: 10.7861/clinmedicine.11-5-502
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Lesson
    • Discussion
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Lesson of the month 1: Broken heart in the intensive care unit
  • Lesson of the month 1: Sudden onset postural livedo reticularis, cyanotic toes and multiorgan failure
  • Lesson of the month (1): Cabergoline – ‘I eat funny on that’
Show more Lesson of the month (1)

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians